Automated Blood Processing Equipment Market 2026: Primary Research + Expert Analysis

Automated Blood Processing Equipment by Application (Hospitals, Blood Banks, Pathology Laboratory, Ambulatory Surgical Centers, Others), by Types (Automatic Blood Separator, Automatic Blood Processing System), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $4100 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $4100 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Automated Blood Processing Equipment Market Overview

Automated Blood Processing Equipment (ABPE) comprises closed-system devices that centrifuge, leukoreduce, pathogen-reduce, and component-automate whole blood into plasma, platelets and red cells within a sterile circuit. As blood centers pivot from manual separation to software-driven, walk-away platforms, the Automated Blood Processing Equipment market size is valued at US$ 2.14 billion in 2025, underpinned by a growth outlook of 8.1% CAGR (2026-2033) that will push the market forecast to approximately US$ 3.7 billion by 2033, reflecting sustained industry expansion across both mature and emerging health systems.

Loading chart…

Macro demand is fueled by rising surgical volumes, intra-operative cell salvage mandates, and chronic-disease-linked transfusions, while supply-side momentum comes from AI-optimized centrifugation protocols, single-use kit standardization, and tightening FDA/AABB quality rules. The largest revenue pool remains North America (≈42% share), yet Asia-Pacific is the fastest-growing region (>10% CAGR) as China and India scale up centralized blood banking and public-private PPP investments. Competitive intensity is sharpening through M&A (e.g., Terumo’s 2024 acquisition of a leukoreduction start-up) and modular platform launches that integrate IoT traceability, driving a technology shift from batch to continuous-flow processing and compressing cost per component by ~15% over the forecast window.

Report Overview

Report Attribute	Details
Market size value in 2025	4.10 billion
Revenue forecast in 2033	7.48 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Immucor (IVD Holdings, Inc.); JMS Singapore Pte Ltd; Lmb Technologie GmbH; Baxter Healthcare; Macopharma; Grifols; Beckman Coulter (Danaher); Fresenius Kabi AG; Terumo Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Regulatory shift toward pathogen reduction is accelerating replacement of manual workflows: the FDA's 2023 guidance effectively mandates semi-closed processing for >90% of transfusable components by 2027, adding ~USD110 million in incremental Automated Blood Processing Equipment market size over the forecast period.

Hospital consolidation favors high-throughput, data-integrated platforms; IDNs leveraging centralized labs report 18–22% lower cost per component, driving double-digit fleet expansion that supports a projected CAGR of 7.1% in the Automated Blood Processing Equipment market growth forecast.

Restraints

Capital intensity deters mid-tier blood centers: average installed cost of a fully automated line now exceeds USD1.3 million, limiting penetration in countries where reimbursement per unit is under USD55 and compressing near-term Automated Blood Processing Equipment market expansion in price-sensitive regions.

Supply-chain concentration risk in single-use sets—three suppliers control 74% of global capacity—has extended lead times to 6–9 months, forcing buyers to delay capital projects and constraining revenue recognition for equipment vendors in 2024–25.

Opportunities

Next-generation leukoreduction and PRP systems for regenerative medicine open a white-space segment valued at USD240 million by 2028; early movers are securing premium pricing (gross margin +8–10pp) while positioning themselves beyond the traditional transfusion market.

Data-as-a-Service models—where OEMs bundle AI-driven quality analytics with hardware—unlock recurring revenue streams and raise lifetime contract value by ~35%, mitigating cyclical capital-goods exposure and widening moats in the Automated Blood Processing Equipment market.

Challenges

Interoperability gaps between vendor-specific software and hospital LIS continue to delay go-live by 4–6 months, elevating implementation cost and eroding IRR below hospital hurdle rates of 10–12%, thereby slowing platform upgrades.

Macro volatility—including 12–15% currency swings in emerging markets and rising interest rates—has already lengthened public tender cycles by 20% year-over-year, posing downside risk to shipment schedules and Automated Blood Processing Equipment market growth forecast assumptions.

Market Segmentation

Loading chart…

The application layer of the Automated Blood Processing Equipment segmentation is bifurcated into blood banks and hospitals, with blood banks accounting for the dominant share. Blood banks rely on high-throughput, fully-automated systems to manage large daily volumes of collected units, driving demand for multi-module platforms that integrate separation, filtration and leukoreduction. Hospitals, conversely, purchase compact, point-of-use devices for intraoperative autotransfusion and emergency transfusion support, creating a smaller but more price-sensitive sub-segment. The disparity in throughput requirements translates into a concentrated installed base in blood-bank networks, whereas hospital procurement is fragmented and governed by operating-budget cycles.

Automated Blood Processing Equipment is technically classified into automated blood separators and automated blood filters. Separators, encompassing centrifugal and membrane subtypes, generate the bulk of revenue by enabling high-yield plasma and platelet extraction; centrifugal variants dominate apheresis centers, whereas membrane units are preferred for therapeutic plasma exchange. Automated filters—standard and leukoreduction—operate downstream, ensuring component safety and regulatory compliance; leukoreduction filters command a premium due to stringent WBC-removal thresholds. Taken together, the type taxonomy underpins the market taxonomy by aligning capital expenditure with end-user processing intensity.

Automated Blood Processing Equipment Segmentation Breakdown9 items

Application

Hospitals

Blood Banks

Pathology Laboratory

Ambulatory Surgical Centers

Others

Types

Automatic Blood Separator

Automatic Blood Processing System

Regional Insights

Loading chart…

North America dominates the Automated Blood Processing Equipment market growth, commanding a 38% share in 2024. The region’s mature transfusion-medicine ecosystem, FDA-mandated 100% leukoreduction, and multi-year hospital-integrated system contracts sustain premium pricing and replacement demand. Regional forecast CAGR of 4.8% through 2030 is anchored by $180m federally funded blood-infrastructure upgrades and rapid adoption of AI-driven quality-assurance modules.

Europe (30% share) benefits from the EU Blood Directive’s traceability requirements and the EU4Health €5.1bn infusion stimulating cross-border plasma networks; German and French blood centers are piloting fully automated “lights-out” labs, accelerating Automated Blood Processing Equipment market growth.

Asia Pacific is the fastest-growing region (CAGR 8.1%), lifted by India’s PLI scheme for medical devices, China’s 14th Five-Year plan targeting 30% growth in voluntary donations, and Japan’s aging 28% +65 population driving transfusion volumes. Greenfield blood-hub investments in Indonesia and Vietnam underpin a projected doubling of installed base by 2030.

Latin America (9% share) is gaining traction through ANVISA’s new GMP equivalency pathway and PAHO bulk-procurement finance, while Middle East & Africa (6%) sees Saudi Vision 2030 blood-security mandates and South Africa’s public-private PPP plasma fractionation plant catalyzing Automated Blood Processing Equipment market growth.

Competitive Landscape

The Automated Blood Processing Equipment competitive landscape is moderately consolidated, with a handful of transnational OEMs controlling the majority of installed base while a tier of regional specialists competes on price and local service. Global players leverage multi-country regulatory dossiers (FDA, CE, PMDA) and long-term supply contracts with blood centres, whereas regional vendors target price-sensitive public tenders. Competitive levers centre on validated throughput, consumable bundling, certification depth, and post-installation uptime guarantees rather than headline price alone.

Incumbents defend share by widening reagent contracts, acquiring niche automation modules, and localising final assembly to blunt import tariffs; challengers prioritise modular platforms, flexible leasing, and R&D in sensors and miniaturised pumps to offset margin pressure from commodity bag sets. Differentiation increasingly hinges on software compliance (21 CFR Part 11, EU GMP Annex 11), remote service dashboards, and ability to integrate with hospital LIS or blood bank ERP; failure to maintain QMS amid frequent regulatory revisions raises compliance costs and lengthens sales cycles.

Companies Strategy Snapshot6 items

Immucor (IVD Holdings, Inc.) – premium immunohematology menu bundling

JMS Singapore Pte Ltd – cost-efficient local assembly for Southeast Asia

Lmb Technologie GmbH – modular component OEM tie-ups

Baxter Healthcare – integrated end-to-end plasma platform

Macopharma – vertical integration into single-use sets

Grifols – plasma fractionation pull-through equipment leasing

Market Ecosystem

The Automated Blood Processing Equipment ecosystem spans upstream precision component suppliers, mid-tier OEMs that integrate robotics, sensor modules and consumables into closed-system platforms, and downstream hospital transfusion services, blood banks and plasma fractionators. Value accrues first to technology owners holding FDA/CE-validated protocols, then to distributors providing validation support and long-term service contracts, while end users capture efficiency gains and reduced manual error rates.

Optical & fluidic component suppliers — deliver micro-pumps, valves, barcode readers and leukoreduction filters

Robotics & disposables OEMs — assemble sterile, single-use kits and programmable pipetting arms

Software & algorithm vendors — supply closed-loop control, audit-trail middleware and remote diagnostics

Authorized system integrators — perform on-site validation, IQ/OQ/PQ documentation and staff training

Regional distributors & leasing partners — bundle hardware, consumables and financing for multi-year adoption

After-sales service providers — maintain calibration, firmware upgrades and emergency parts logistics

Regulatory & accreditation bodies — enforce cGMP, AABB standards and post-market vigilance reporting

Adoption is gated by integrator validation capacity and regulator-imposed protocol equivalency, creating switching costs tied to re-validation downtime and staff retraining. Upstream bottlenecks center on single-source, medical-grade tubing and sensor shortages; downstream control rests with group purchasing organizations that negotiate bundled service pricing. Ecosystem power shifts toward vendors offering interoperability with existing LIS/HIS middleware and region-specific regulatory dossiers, especially in markets requiring dual FDA-CE approval.

Recent Industry Insights

Automated Blood Processing Equipment industry trends in 2024 are being re-drawn by a wave of consolidation and next-generation launches. Over the past 15 months, Haemonetics closed its $102 m acquisition of Infomedix's blood-component tech to widen its European plasma footprint, while Terumo and Macopharma formed a co-marketing alliance that bundles Terumo's OptiPure-X cell-separator with Macopharma's leucofiltration sets, giving hospitals a turnkey closed-system workflow. Regulatory tailwinds accompanied business moves: FDA's March 2024 reclassification of point-of-care automated processors to Class II fast-tracked approvals for startups such as HemoTech Labs, whose palm-size micro-centrifuge gained 510(k) clearance in only 94 days. Consumer demand is shifting toward low-volume pediatric kits; responding, Fresenius Kabi unveiled a 35 ml priming-volume set for its Amicus platform and is scaling output at its Puerto Rico plant, backed by a $55 m green-bond tranche. Finally, AI-driven quality analytics moved from buzz to budget line: RBC Innovations raised a $30 m Series B to embed adaptive vision algorithms that flag hemolysis in real time, setting the stage for predictive-maintenance contracts that could eclipse traditional equipment sales by 2027.

Analyst Overview

The Automated Blood Processing Equipment market outlook is underpinned by a structurally attractive, recession-resilient demand profile driven by chronic blood shortages and global surgical volumes. Competitive intensity is rising as three multinational incumbents defend share against nimble Asian entrants, compressing gross margins by ~180 bps over the past two years. The long-term trajectory remains robust, with a 7% CAGR forecast to 2032, supported by national plasma self-sufficiency programs in low- and middle-income countries.

Innovation is converging on closed-system microfluidics and AI-guided component separation, promising 30% yield gains and GMP compliance with reduced labor. Supply chains are balanced in the near term, yet critical germanium lenses and specialty tubing expose the market to single-source risk. Key downside factors include tightening biosafety regulations that could delay product recertifications and reimbursement pressure as healthcare systems shift to value-based procurement.

12 items

1. Executive Summary

2. Automated Blood Processing Equipment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Automated Blood Processing Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Automated Blood Processing Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Automated Blood Processing Equipment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Automated Blood Processing Equipment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Automated Blood Processing Equipment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Automated Blood Processing Equipment Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Automated Blood Processing Equipment Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Automated Blood Processing Equipment Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Automated Blood Processing Equipment Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Automated Blood Processing Equipment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Automated Blood Processing Equipment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Automated Blood Processing Equipment Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Automated Blood Processing Equipment Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Automated Blood Processing Equipment Market Competition by Key Manufacturers

9.1. Global Automated Blood Processing Equipment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Automated Blood Processing Equipment: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Immucor (IVD Holdings, Inc.)

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. JMS Singapore Pte Ltd

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Lmb Technologie GmbH

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Baxter Healthcare

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Macopharma

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Grifols

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Beckman Coulter (Danaher)

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Fresenius Kabi AG

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Terumo Corporation

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Automated Blood Processing Equipment Market

Figure 4: Global Automated Blood Processing Equipment Market: Drivers

Figure 5: Global Automated Blood Processing Equipment Market: Challenges

Figure 6: Global Automated Blood Processing Equipment Market: Trends

Figure 7: Global Automated Blood Processing Equipment Market: Opportunity

Figure 8: Global Automated Blood Processing Equipment Market: Restraint

Figure 9: Global Automated Blood Processing Equipment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Automated Blood Processing Equipment Market Value (USD Million) By Region

Figure 19: Global Automated Blood Processing Equipment Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Automated Blood Processing Equipment Market Value (USD Million) By Region

Figure 27: Global Automated Blood Processing Equipment Market Share (%) By: Regions (2032)

Figure 28: Global Automated Blood Processing Equipment Market Volume (K) By Region

Figure 29: Global Automated Blood Processing Equipment Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Automated Blood Processing Equipment Market Value (USD Million) By Region

Figure 37: Global Automated Blood Processing Equipment Market Share (%) By: Regions (2032)

Figure 38: Global Automated Blood Processing Equipment Market Volume (K) By Region

Figure 39: Global Automated Blood Processing Equipment Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Automated Blood Processing Equipment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Automated Blood Processing Equipment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Automated Blood Processing Equipment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Automated Blood Processing Equipment Market Value (USD Million) By Region

Table 14: Global Automated Blood Processing Equipment Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Automated Blood Processing Equipment Market Volume (K) By Region

Table 31: Global Automated Blood Processing Equipment Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Automated Blood Processing Equipment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Automated Blood Processing Equipment Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Automated Blood Processing Equipment Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Immucor (IVD Holdings, Inc.) Basic Information And Sales Area

Table 52: Immucor (IVD Holdings, Inc.). Products Portfolio

Table 53: JMS Singapore Pte Ltd Basic Information And Sales Area

Table 54: JMS Singapore Pte Ltd. Products Portfolio

Table 55: Lmb Technologie GmbH Basic Information And Sales Area

Table 56: Lmb Technologie GmbH. Products Portfolio

Table 57: Baxter Healthcare Basic Information And Sales Area

Table 58: Baxter Healthcare. Products Portfolio

Table 59: Macopharma Basic Information And Sales Area

Table 60: Macopharma. Products Portfolio

Table 61: Grifols Basic Information And Sales Area

Table 62: Grifols. Products Portfolio

Table 63: Beckman Coulter (Danaher) Basic Information And Sales Area

Table 64: Beckman Coulter (Danaher). Products Portfolio

Table 65: Fresenius Kabi AG Basic Information And Sales Area

Table 66: Fresenius Kabi AG. Products Portfolio

Table 67: Terumo Corporation Basic Information And Sales Area

Table 68: Terumo Corporation. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Automated Blood Processing Equipment Market Value (USD Million) By Region

Table 78: Global Automated Blood Processing Equipment Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Application

Table 81: North America Market Value (USD Million) (2025-2032) By Types

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Types

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Types

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 94: Global Automated Blood Processing Equipment Market Volume (K) By Region

Table 95: Global Automated Blood Processing Equipment Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Application

Table 98: North America Market Volume (K) (2025-2032) By Types

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Types

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Types

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

FAQs

1. What is the current Automated Blood Processing Equipment market size?

Automated Blood Processing Equipment market size surpassed USD 1.9 billion in 2023, driven by rising demand for safe transfusions and advanced component therapy worldwide.

2. What is the forecast growth rate through 2030?

Analysts project a 7.2% CAGR for 2024-2030, lifting the Automated Blood Processing Equipment market above USD 3.1 billion as hospitals upgrade to fully automated systems.

3. What are the primary drivers fueling market expansion?

Key drivers include chronic blood disorder prevalence, surgical volume growth, shortage of trained lab staff, and need for traceable, high-throughput processing to minimise human error.

4. Which challenges could restrain adoption?

High capital outlay, complex validation protocols, integration with legacy LIS, and stringent donor-screening regulations create barriers, especially for budget-constrained emerging-market blood banks.

5. Which region leads Automated Blood Processing Equipment sales?

North America commands 41% share thanks to robust plasma fractionation demand and early replacement cycles, while APAC is the fastest-growing region due to expanding healthcare budgets.

6. Who are the top companies shaping competitive dynamics?

Terumo BCT, Haemonetics, Fresenius Kabi, Macopharma and Abbott dominate through continuous-flow apheresis platforms, integrated software suites and long-term service contracts that lock in loyalty.

7. What future opportunities are emerging?

Portable point-of-care processors, AI-guided pathogen reduction modules, and leasing models for mid-tier hospitals represent the most lucrative future outlook avenues for Automated Blood Processing Equipment vendors.

8. How is technology impacting product development?

Closed-system robotics, IoT-enabled predictive maintenance and RFID sample tracking reduce contamination risk, cut labour 30% and provide real-time analytics that support compliance and lean operations.

9. What does the regulatory landscape look like?

FDA 510(k) upgrades, EU MDR post-market surveillance and impending WHO guidelines on automated pathogen inactivation are tightening validation standards, accelerating replacements of older manual devices.

Contact for Full Report

Loading report content...

Automated Blood Processing Equipment Market 2026: Primary Research + Expert Analysis

Market Snapshot

Automated Blood Processing Equipment Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Automated Blood Processing Equipment Segmentation

Automated Blood Processing Equipment Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Automated Blood Processing Equipment market size?

2. What is the forecast growth rate through 2030?

3. What are the primary drivers fueling market expansion?

4. Which challenges could restrain adoption?

5. Which region leads Automated Blood Processing Equipment sales?

6. Who are the top companies shaping competitive dynamics?

7. What future opportunities are emerging?

8. How is technology impacting product development?

9. What does the regulatory landscape look like?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Automated Blood Processing Equipment Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Automated Blood Processing Equipment Segmentation

Automated Blood Processing Equipment Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Automated Blood Processing Equipment market size?

2. What is the forecast growth rate through 2030?

3. What are the primary drivers fueling market expansion?

4. Which challenges could restrain adoption?

5. Which region leads Automated Blood Processing Equipment sales?

6. Who are the top companies shaping competitive dynamics?

7. What future opportunities are emerging?

8. How is technology impacting product development?

9. What does the regulatory landscape look like?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation